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Abstract 
 
Background: Dorema Ammoniacum is a perennial herb which has been used in Persian Traditional Medicine for different 
indications, including gastrointestinal disorders and sciatica. Despite numerous medicinal uses, there is a lack of 
toxicological studies on Dorema Ammoniacum; therefore, the aim of the present study is to investigate its possible toxic 
effects as well as the determining chemical composition of its essential oil.  
Materials and Methods: Acute toxicity study was performed by administration of single increasing geometric doses of 
oleo-gum-resin solution (1250, 2500, and 5000 mg/kg) to Wistar rats. For sub-acute toxicity study, repeated doses of oleo-
gum-resin solution (100, 200 and 500 mg/kg) were administered orally to rats for 4 weeks. At the end of the treatment, 
histopathological studies, hematological assessments, and biochemical parameters were performed.  
Results: GC-MS was performed to determine the chemical composition of the essential oil. Acute toxicity results 
demonstrated no mortality, and the Median Lethal Dose (LD50) was greater than 5000 mg/kg. Sub-acute treatment did not 
show any significant changes in biochemical and hematological parameters at any doses compared to the control group. 
Histopathological analysis of the organs revealed varying effects. At the level of the liver, vacuolar degeneration and mild 
inflammation at 200 and 500 mg/kg doses were observed. At the level of kidney, congestion of glomeruli and a widening of 
the urinary space at 500mg/kg were observed compared to the control group. The principle components of the essential oil 
were Cuperene (14.31%) and β-Funebrene (12.74%).  
Conclusion: The results suggest that the acute administration of the oleo-gum-resin of D. Ammoniacum is not accompanied 
with signs of toxicity; however, its administration over the long term might associate with renal toxicity and hepatotoxicity. 
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Introduction 
 
The genus Dorema from Apiaceae family includes 12 species that are mainly distributed in central and southwest 
Asia. In Iran, this genus is represented by seven species, one of which is Dorema Ammoniacum D. Don. (Flora of the 
U.S.S.R, 1974). D. Ammoniacum is a monocarpic perennial plant which grows up to 2.5m high in Iran, Afghanistan, 
Pakistan, and North India. In Iran, it is known by the local Persian names of “Oshagh”, “Vasha”, “Kandal”, “Koma-
Kandal” (Mozaffarian, 2008). Its naturally-exuding oleo-gum-resin latex, commonly known as gum ammoniacum, is found 
in cavities, stems, roots, and petioles. It serves as an antispasmodic, expectorant, carminative, diaphoretic, mild diuretic, 
poultice, stimulant, antimicrobial, spleen and liver tonic, anticancer, and vasodilator (V M Flora of Iran, Eskandani et al., 
2014, Javadi et al., 2015, Naghibi et al., 2015, Sharafzadeh et al., 2012). Recently, a low cytotoxic activity was detected for 
the essential oil of D. Ammoniacum fruit. Several studies have proved significant antimicrobial activity of the fruit essential  
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oil and oleo-gum-resin from D. ammoniacum (Rajani et al., 2002, Shahidi et al., 2002, Yousefzadi et al., 2011). Abizadeh 
et al. reported that oleo-gum-resin has anticonvulsant effect on PTZ- induced model of epilepsy (Abizadeh et al., 2014).  
Since there is a lack of toxicological studies despite the various pharmacological activities, this study is designed to 
evaluate acute and sub-acute toxicity of D. Ammoniacum oleo-gum-resin. Moreover, due to the lack of studies on the 
chemical constituents of gum ammoniac, the chemical composition of the essential oil of the mentioned oleo-gum-resin has 
also been investigated. 
  
Materials and Methods 
Test Substance 
 
The oleo-gum-resin (DAOGR) was purchased from the market, and was authenticated by the botanist as Dorema 
Ammoniacum D. Don. (voucher number: PMP-823). Afterwards, DAOGR was grounded, sieved from mesh 30, and 
dissolved in distilled water for oral administration. 
 
The Composition the Essential Oil of DAOGR 
 
The essential oil of oleo-gum-resin was obtained by steam-distillation method using Clevenger apparatus. The 
essential oil was analyzed by using an Agilent 7890 gas chromatography (GC) system equipped with a HP5 column (30 m× 
0.25mm, film thickness 0.25 µm). The column temperature was programmed from 60
°
C to 250
°
C, and being held for 5 
minutes at a rate of 3
°
C/min; it also was programmed to 300
°
C, and being held for 3 minutes at a rate of 10
°
C/min. The 
injector temperature was set at 290
°
C. Helium was used as a carrier gas with a flow rate of 0.8 mL/min. Mass spectroscopy 
was Agilent 5973 model mass detector with electron ionization (EI) system with ionization energy of 70 eV, and the 
ionization source temperature was set to 220
°
C. For GC and GC-MS analysis, 1µL of the essential oil dissolved in hexane 
was injected by the split mode (1:25). Electronic integration of the FID peak areas was used for determination of the 
quantitative data. MSD Chemstation software (Aglient Technologies) was used for data analysis. Components were 
identified by using their retention times to n -alkanes compared to those of Wiley 275 library and those described by Adams 
(Farzaei et al., 2014; Adams, 2004). 
 
Animals 
 
Eighty healthy, 8-week-old Wistar albino rats consisting of 40 males (230 ± 5 g) and 40 females (210 ± 5 g) were 
selected from the animal lab of the Faculty of Pharmacy at Tehran University of Medical Sciences, Tehran, Iran. 
The animals were housed in a room temperature (22 ± 2°C), a relative humidity of 50±20%, and 12h/12h light/darkness, 
and were fed with commercial standard rat chow and water ad libitum. All the ethical guidelines for use of laboratory 
animals were followed carefully , and the study was ethically approved by TUMS (Tehran University of Medical Sciences) 
Review Board. Following several days of acclimatization, rats were randomly assigned to control and experimental groups.  
 
Acute oral toxicity 
 
Forty rats were randomly divided into four groups, each of which consisting of ten animals (n=5 male and n=5 
females): a control (Group 1) and three dose level groups (Group 2, 3, and 4) received a single dose of 1250, 2500 and 5000 
mg/kg body weight, respectively. DAOGR was administered once by oral gavage at 10ml/kg body weight while distilled 
water was administered to control group. After administration, the animals were first observed every half hour for 4 hour, 
and daily thereafter. Changes in eyes, skin and fur, and mucus membrane (nasal), as well as the behavioral changes such as 
salivation, diarrhea, and body weight were observed and recorded separately for each animal in comparison to the controls 
during the experiment. On day 14, after administration, the animals were sacrificed by chloroform inhalation, and their 
external surface, thoracic organs, and abdominal organs and contents were macroscopically examined (kebede et al., 2016, 
Lee et al., 2015).  
 
Four-week Repeated-dose Oral Toxicity (Sub-acute Toxicity) 
 
The remaining rats were randomly distributed into four groups (n=5 males and 5 females/ group):  a control 
(Group 1) and three dose level groups (Groups 2, 3, and 4) were administered 100, 200, and 500mg/kg body weight/day, 
respectively. DAOGR was administered by oral gavage at 10ml/kg body weight on a daily basis for 4 weeks. The control 
animals were treated with the same volume of distilled water.  
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In vivo Observation  
 
During the experiment, the animals were observed for signs of toxicity and mortality twice a day. Detailed 
toxicological signs were assessed and recorded, including changes in skin and fur, eyes, mucous membranes, manure, 
behavioral patterns, etc. (Lee et al., 2015, Xie et al., 2013). 
 
Ophthalmoscopy 
 
Eye examination was performed shortly before the start of the experiment and prior to its termination according to 
the methods prescribed by Lee et al., 2015 (Lee et al., 2015).  
 
Body Weight: The body weight was measured at the onset and once a week during the experiment. 
 
Food Intake 
  
The amounts of food were weighed before being supplied to each cage, and their remnants were also measured the 
next day. The differences were reported as daily feed consumption.  
 
Hematology and Serum Biochemistry 
 
Hematological and biochemical parameters have been assessed according to methods described previously (Lee et 
al., 2015, Xie et al., 2013). 
 
Organ Weights  
 
At the end of the treatment period, all male and female rats were anesthetized by chloroform. The anesthetized 
animals were sacrificed, and then decapitated for blood collection. Complete gross postmortem examination was performed 
on all animals. All organs were carefully examined macroscopically. Afterwards, the liver, lungs, heart, kidneys, spleen, 
and stomach were separated and after fat removal, all of their connective tissues and blood were weighed (Lee et al., 2015, 
Xie et al., 2013).   
 
Histopathology 
 
Hematoxylin and eosin staining was used for microscopic examination of organs, including brain, thyroid glands, 
stomach, small intestine, large intestine, pancreas, lungs, spleen, kidneys, liver, heart, bladder, testes, ovaries, uterus, and 
prostate gland (Lee et al., 2015, Xie et al., 2013).   
 
Statistical Analysis 
 
The data are expressed as the means ± SEM. The data were analyzed by the one-way analysis of variance 
(ANOVA) followed by Fisher’s Least significant difference test using SPSS program. Data from male and female animals 
were analyzed separately. A P˂0.05 was considered significant. 
 
Results 
The Essential Oil Yield and Composition 
 
The yield of essential oil extraction was 0.6% seperately. Forty-two constituents were identified that represented 
60.05% of the total oil. The chemical composition of the essential oil is demonstrated in table 1. The principle components 
of the essential oil were Cuperene (14.31%) and β-Funebrene (12.74%).  
 
 
 
 
 
 
 
 
 
29 
 
 
Table 1: The essential oil composition of Dorema Ammoniacum of oleo-gum-resin 
 Retention Time Area% A1 Compound 
1 17.87 14.31 Cuparene 
2 15,65 12.74 β-Funebrene 
3 16,38 9.21 Barbatene 
4 17,27 7.46 Germacrene D 
5 10,98 6.68 Z-Ocimenone 
6 17.92 4.91 Bisabolene 
7 16,58 4.25 α-Humulene 
8 16,67 3.85 Amorpha-4,11-diene 
9 11.17 3.31 E-Ocimenone 
10 8.34 3.23 2,6-Dimethyl3,5,7-octatriene-2-ol,,Z,Z 
11 17.18 3.13 β-Chamigrene 
12 4.2 2.89 α-Pinene 
13 16.33 2.5 Guaiadiene 
14 11.02 2.43 Thymol methylether 
15 15.03 2.38 β-elemene 
16 15.74 2.13 Trans-caryophyllene 
17 17.71 1.83 Himachalene 
18 18.24 1.68 δ-Cadinene 
19 10.36 1.49 2,6-Dimethyl3,5,7-octatriene-2-ol,,E,E 
20 14.62 1.36 α-Copaene 
21 16.45 1.31 β-Selinene 
22 17.59 1.27 α-Selinene 
23 16.73 0.56 Acoradiene 
24 15.79 0.56 Cedrene 
25 18.47 0.55 γ-Cuprenene 
26 16.19 0.54 Elemene 
27 4.96 0.45 β-pinene 
28 18.39 0.44 Dauca-4(11),8-diene 
29 19.04 0.35 Dauca-4(11),8-diene 
30 14.85 0.34 β-burbonene 
31 16.88 0.33 Aromadendrene 
32 21.8 0.28 Bulnesol 
33 17.38 0.27 β-selinene 
34 16.03 0.27 Thujopsene 
35 8.1 0.24 2,6-Dimethyl1,3(E)-5(Z),octatetraene 
36 19.9 0.14 Caryophyllene oxide 
37 9.26 0.13 Dimercaprol 
38 10.12 0.07 Myrtenol 
39 13,92 0.05 α-cubebene 
40 5.88 0.04 p-cymene 
41 5.96 0.02 Limonene 
42 4.06 0.01 α-thujene 
Total identified: 60.05 
 
Acute Oral Toxicity Evaluation 
 
No animal death was recorded during the experiment. The animals did not manifest any significant DAOGR-
related effects evident concerning the toxicological signs, body weight changes, and macroscopic findings at any time of 
observations and at any administered doses. Autopsy results showed no remarkable changes or lesions in any animal.  
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Repeated Dose 28-Day Oral Toxicity (Sub-acute Toxicity) 
General Appearance, Body Weight, Food Intake, and Water Consumption 
 
In sub-acute toxicity study, no death or remarkable changes of toxicological signs associated with the 
administration of DAOGR were observed during the experiment at any administered doses. In addition, there were no 
statistically significant changes in body weight in the DAOGR-treated groups compared to the control group. No 
statistically significant differences in food consumption of male rats were recorded between the control and treatment 
group; however, a statistically significant increase in food consumption was observed in the 200mg/kg-administered female 
groups on week 2 and 4 compared to control group (P˂0.05).  
 
Hematological and Biochemical Findings 
 
There were no significant changes in the hematological or biochemical parameters in rats after 28 days of DAOGR 
treatment (Table 2). 
 
Table 2: Hematological and biochemical parameters of sub-acute oral administration of DAOGR (4 weeks) 
 Sex Dose 0 Dose 100 Dose 200 Dose 500 
RBC (M/µL) Male 9.2±1.17 9.2±2.27 8.4±2.33 8.9±2.29 
Female 9.3±0.98 9.1±2.13 9.2±2.31 9.1±2.2 
Hb (g/dl) Male 16.7±2.1 16.9±1.4 14.9±4.5 15.7±4.3 
Female 16.3±1.1 15.9±0.87 15.9±3.5 15.7±4.3 
HCT 
(%) 
Male 46.5±4.6 48.5±3.9 41.9±12.7 43.3±12.2 
Female 45.5±3.1 46.5±4.2 46.7±5.1 44±6.3 
MCV 
(fl) 
Male 50.6±1.8 52.8±2.9 50.2±14.3 48.8±13.6 
Female 51.1±2.5 48.8±3.2 49.1±3.6 52.3±5.6 
MCH 
(pg) 
Male 18.1±0.28 18.3±0.58 17.8±5.1 17.6±4.9 
Female 18.2±0.67 18.1±0.29 18.8±4.3 17.6±3.3 
Platelet count 
(1000/µL) 
Male 448.6±78.5 613.7±70.4 501.8±158.5 481.2±152.6 
Female 538.5±45.1 593.3±56.1 532.5±134 498.5±96 
WBC 
(1000/µL) 
Male 8.3±1.6 7.5±2.1 7.8±2.7 9.4±3.04 
Female 8.1±0.4 7.5±2.1 6.8±3.1 7.4±3.2 
LYM 
(%) 
Male 79.3±3.01 71.8±9.1 67.7±20.6 69.03±9.9 
Female 69.3±7.1 71.6±8.5 68.7±10.1 69.4±5.8 
MON 
(%%) 
Male 5.27±3.01 6.8±2.06 6.48±2.4 5.02±2.4 
Female 6.88±1.4 6.02±3.45 6.48±1.1 6.02±3.7 
PT (s) Male 11.5±0.9 12.1±0.7 12.1±0.4 11.9±0.3 
Female 10.1±0.8 9.1±0.4 9.2±0.3 8.9±0.4 
Blood Sugar 
(mg/dl) 
Male 156.3±13.5 167.3±46.3 170.3±46.2 144.1±45.5 
Female 160.1±11.2 170.4±21.3 170.4±11.3 156.2±46.2 
Blood Urea 
Nitrogen(mg/dl) 
Male 50.66±2.6 63.2±16.1 54.7±15.2 55.7±14.9 
Female 54.7±16.1 56.2±3.1 61.3±15.1 55.7±14.5 
Cholesterol 
(mg/dl) 
Male 65±4.3 81.6±20 59.7±19.5 56.5±18.9 
Female 67±11.1 69.2±6.6 58.3±14 58.2±11.5 
Triglycerides 
(mg/dl) 
Male 156±47.9 143.4±41.6 147.1±39.8 146±38.9 
Female 147.4±19.1 146±50.2 147.1±36 156±28.4 
AST (U/L) Male 131±18.5 114.5±32.4 118.2±32.4 129.5±33.6 
Female 124±26.1 128.2±22.4 119.5±22.1 118.1±41.1 
ALT (U/L) Male 44±5.4 33.8±6.7 41.8±9.9 46.7±11.5 
Female 43±2.4 43.8±3.5 41.8±6.9 44.7±2.4 
ALP (U/L) Male 350.3±88.8 312.3±96.8 457.2±133.7 391.6±135.3 
Female 368±56.1 380.6±76 417.1±78.4 407.2±102.5 
Total Protein 
(g/dl) 
Male 6.7±0.3 7.7±1.8 6.3±1.8 6.5±1.8 
Female 7.1±1.3 6.3±0.8 6.5±1.2 7.1±0.3 
LDH(U/L) Male 1292.5±305.8 998.3±347.7 1046.8±356.2 1029±382.9 
Female 999.8±361.7 1045.8±344.5 1019±412.9 1020.8±350.2 
CREA (mg/dl) Male 0.63±0.04 0.7±0.17 0.63±0.17 0.62±0.17 
Female 0.58±0.09 0.63±0.07 0.58±0.07 0.61±0.16 
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Organ Weight  
 
The organ weight changes were not considered to be associated with the toxicological changes between the control 
group and DAOGR-treated group at the end of the experiment for either gender. 
 
Histopathology Findings 
 
Histopathology analysis of organs’ portions after treatment with DAOGR revealed varying effects. The major 
pathological findings included some toxicity signs in the liver and the kidneys. At the level of the liver, vacuolar 
degenerescence and mild inflammation at 200 and 500 mg/kg doses were observed. At the level of the kidneys, congestion 
of glomeruli and a widening of the urinary space at 500mg/kg dose in comparison to the control group were observed 
(Figure 1). 
 
Discussion and Conclusion  
 
Despite a wide variety of preclinical and clinical studies to evaluate efficacy of medicinal herbs, the number of 
investigations addressing their safety and toxicity are few (Xie et al., 2013). Because of the extensive use of DAOGR in 
Persian Traditional Medicine, this study intends to evaluate its safety through oral acute and sub-acute (repeated Dose 28-
Day) toxicity tests. Before safety evaluation, the chemical composition of DAOGR’s essential oil was identified by GC-
MS. As mentioned eralier, the principle components of essential oil were cuparene (14.31%) and β-Funebrene (12.74%). 
There are several published papers which describe the structure of some other chemical compounds from Dorema 
Ammoniacum. A spiro-chromene derivative, doremone A, dashamirone, and ammoresinol were identified as major 
compounds in dichloromethane extract of gum resin via HPLC assay analysis (Adhami et al., 2013). The chemical 
composition of the essential oil from Dorema Ammoniacum oleo-gum-resin has been investigated in this study for the first 
time. The chemical composition of the essential oil from Dorema Glabrum revealed delta-Cadinene (12.77%) as the main 
component of the root that is followed by beta-bisabolene (7.48%), alpha-Fenchyl acetate (6.32%), and Copaene (5.68%) 
(Asnaashari et al., 2011); while elemicin (38.6%) and myristicin (14.3%) were reported as main compounds of aerial parts 
(Delnavazi et al., 2015). The investigation of Dorema Aucheri’s essential oil revealed β-caryophyllene, thymol, β-
gurjunene, carvacrol, and cuparene  as the major components (Akbarian et al., 2016). 
The acute toxicity study showed no DAOGR-related mortality or adverse effects at any doses by oral administration during 
14 days. Also, normal body weight gains were observed in the males and females of all dose groups, and the changes in 
body weight were not significant at any doses. 
 
  
Figure 1: Histology of organs of rats exposed to DAOGR for 28 days. a) Liver: vacuolar degenerescence ×
 
100; b) Liver: 
vacuolar degenerescence × 400; c) kidney: congestion of glomeruli; d) kidney: widening of the urinary space 
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The results suggested that acute administration of the oleo-gum-resin of D. Ammoniacum is not associated with 
signs of toxicity, and it leads to estimation of Median Lethal Dose (LD50) DAOGR higher than 5000 mg/kg in rats.  
Daily oral administration of DAOGR for 28 days had no effect on body weight, food and water consumption, absolute and 
relative organ weight, as well as the hematology test. However, histopathological examination of animal groups receiving 
the oleo-gum-resin for 28 days demonstrated some signs of hepatotoxicity and kidney toxicity. Vacuolar degenerescence in 
the liver section could be due to the inflammation or blockage role of the DAOGR on the walls of blood vessels. The 
congestion of glomeruli and widening of the urinary tract may be due to the effect of DAOGR on capillary constriction to 
decrease glomeruli filtration. Mostafavi et al. showed that intraperitoneal injection of Dorema Aucheri leaves extract caused 
necrosis, inflammation of the liver tissue, cell proliferation, cholestasis, and significant increase in release of liver enzymes 
(ALP, SGPT and SGOT) and bilirubin in mice (Mostafavi et al., 2013). However, Ahangarpour et al. demonstrated 
hepatoprotective effects of Dorema Aucheri leaves hydroalcoholic extract in nicotinamide-streptozotocin induced type 2 
diabetic rats at dose of 200 mg/kg for 4 weeks by reversing back the elevated level of liver enzymes (SGOT and SGPT) 
(Ahangarpour et al., 2014). 
In conclusion, it seems that DAOGR is safe in acute administration, however, long term use might be associated with sign 
of hepatotoxicity and kidney toxicity. Sub-chronic studies are recommended to confirm obtained results. 
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